The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.
Open accessAbstract
The hormonal form of vitamin D, 1,25-dihydroxyvitamin D3, acting through its cognate nuclear receptor (vitamin D3 receptor, VDR) will induce myeloid leukemic cell lines to terminally differentiate into monocytes/macrophages. Because VDR acts by transcriptionally regulating responsive genes in a ligand-dependent manner, we sought target genes of the receptor that initiate, the differentiation process in response to ligand. We screened a cDNA library prepared from the myelomonocytic U937 cell line with probes generated from either 1,25-dihydroxyvitamin D3-treated or untreated cells. We report here that a candidate clone that hybridized differentially is the Cdk inhibitor p21WAF1, CIP1. Furthermore, we show that p21 is transcriptionally induced by 1,25-dihydroxyvitamin D3 in a VDR-dependent, but not p53-dependent, manner, and we identify a functional vitamin D response element in the p21 promoter. Transient overexpression of p21 and/or the related Cdk inhibitor p27 in U937 cells in the absence of 1,25-dihydroxyvitamin D3 results in the cell-surface expression of monocyte/macrophage-specific markers, suggesting that ligand-modulated transcriptional induction of the p21 gene facilitates the induced differentiation of this monoblastic cell line. We believe that this is the first report demonstrating that the ectopic overexpression of a Cdk inhibitor such as p21 or p27 directly leads to a terminal differentiation program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Self-citationMice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Cited by
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., & Demay, M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0004 · Cited by 1,783
Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription
Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., & Brown, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00188-4 · Cited by 1,657
Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression
Wang, T.-T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., Tavera-Mendoza, L., Lin, R., Hanrahan, J. W., Mader, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.2909 · Cited by 1,637
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J.-C., Thompson, P. D., Selznick, S. H., Dominguez, C. E., & Jurutka, P. W. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.325 · Cited by 1,421
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Deeb, K. K., Trump, D. L., & Johnson, C. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2196 · Cited by 1,419
The role of vitamin D in reducing cancer risk and progression
Feldman, D., Krishnan, A. V., Swami, S., Giovannucci, E., & Feldman, B. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3691 · Cited by 1,311
Current Understanding of the Molecular Actions of Vitamin D
JONES, G., STRUGNELL, S. A., & DeLUCA, H. F. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1193 · Cited by 1,274
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
Dusso, A. S., Brown, A. J., & Slatopolsky, E. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00336.2004 · Cited by 1,148
Melnick, A., & Licht, J. D. (1999) · Blood · doi:10.1182/blood.v93.10.3167.410k44_3167_3215 · Cited by 1,028
Noncalcemic Actions of Vitamin D Receptor Ligands
Nagpal, S., Na, S., & Rathnachalam, R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0002 · Cited by 961
Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis
Novershtern, N., Subramanian, A., Lawton, L. N., Mak, R. H., Haining, W. N., McConkey, M. E., Habib, N., Yosef, N., Chang, C. Y., Shay, T., et al. (2011) · Cell · doi:10.1016/j.cell.2011.01.004 · Cited by 942
Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex
Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J., & Pavletich, N. P. (1996) · Nature · doi:10.1038/382325a0 · Cited by 907
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735
Haussler, M. R., Jurutka, P. W., Mizwicki, M., & Norman, A. W. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.05.010 · Cited by 683
Transcriptional Regulation of the p21(WAF1/CIP1)Gene
Gartel, A. L., & Tyner, A. L. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4319 · Cited by 664
Chen, H., Lin, R. J., Xie, W., Wilpitz, D., & Evans, R. M. (1999) · Cell · doi:10.1016/s0092-8674(00)80054-9 · Cited by 637
Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation
Asada, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1223 · Cited by 586
Ingles, S. A., Ross, R. K., Yu, M. C., Haile, R. W., Irvine, R. A., La Pera, G., & Coetzee, G. A. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.2.166 · Cited by 583
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
Role of PML in Cell Growth and the Retinoic Acid Pathway
Gang Wang, Z., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., Grosveld, F., & Paolo Pandolfi, P. (1998) · Science · doi:10.1126/science.279.5356.1547 · Cited by 517
Yan, Y., Frisén, J., Lee, M. H., Massagué, J., & Barbacid, M. (1997) · Genes & Development · doi:10.1101/gad.11.8.973 · Cited by 493
Self-citationMechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D
Krishnan, A. V., & Feldman, D. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100611 · Cited by 470
MAESTRO, B., CAMPIÓN, J., DÁVILA, N., & CALLE, C. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.383 · Cited by 435
Structural Organization of the Human Vitamin D Receptor Chromosomal Gene and Its Promoter
Miyamoto, K.-I. (1997) · Molecular Endocrinology · doi:10.1210/me.11.8.1165 · Cited by 431
Vitamin D and cancer: a review of molecular mechanisms
Fleet, J. C., Desmet, M., Johnson, R., & Li, Y. (2012) · Biochemical Journal · doi:10.1042/bj20110744 · Cited by 407
The Vitamin D Receptor and the Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets*
Malloy, P. J., Pike, J. W., & Feldman, D. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.2.0359 · Cited by 395
Nakano, K., Mizuno, T., Sowa, Y., Orita, T., Yoshino, T., Okuyama, Y., Fujita, T., Ohtani-Fujita, N., Matsukawa, Y., Tokino, T., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22199 · Cited by 395
Identification of a Vitamin D response element in the human insulin receptor gene promoter
Maestro, B., Dávila, N., Carranza, M. C., & Calle, C. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00032-3 · Cited by 377
Pestell, R. G., Albanese, C., Reutens, A. T., Segall, J. E., Lee, R. J., & Arnold, A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0373 · Cited by 375
Differentiation therapy of leukemia: 3 decades of development.
Nowak, D., Stewart, D., & Koeffler, H. P. (2009) · Blood · doi:10.1182/blood-2009-01-198911 · Cited by 348
Gene disruption of p27 Kip1 allows cell proliferation in the postnatal and adult organ of Corti
Löwenheim, H., Furness, D. N., Kil, J., Zinn, C., Gültig, K., Fero, M. L., Frost, D., Gummer, A. W., Roberts, J. M., Rubel, E. W., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.4084 · Cited by 361
Moustakas, A., & Kardassis, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6733 · Cited by 354
Owen, G. I., Richer, J. K., Tung, L., Takimoto, G., & Horwitz, K. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10696 · Cited by 349
Vitamin D's role in cell proliferation and differentiation: Nutrition Reviews©, Vol. 66, No. s2
Samuel, S., & Sitrin, M. D. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00094.x · Cited by 336
Reynisdóttir, I., & Massagué, J. (1997) · Genes & Development · doi:10.1101/gad.11.4.492 · Cited by 333
Dacapo, a Cyclin-Dependent Kinase Inhibitor, Stops Cell Proliferation during Drosophila Development
Lane, M. E., Sauer, K., Wallace, K., Jan, Y. N., Lehner, C. F., & Vaessin, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81818-8 · Cited by 327
Transcriptional regulation of granulocyte and monocyte development
Friedman, A. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205324 · Cited by 324
Mechanisms of gene regulation by vitamin D3 receptor: a network of coactivator interactions
Rachez, C., & Freedman, L. P. (2000) · Gene · doi:10.1016/s0378-1119(00)00052-4 · Cited by 323
Self-citationHaussler, M. R., Haussler, C. A., Bartik, L., Whitfield, G. K., Hsieh, J.-C., Slater, S., & Jurutka, P. W. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00093.x · Cited by 320
Wu, S., Cetinkaya, C., Munoz-Alonso, M. J., von der Lehr, N., Bahram, F., Beuger, V., Eilers, M., Leon, J., & Larsson, L.-G. (2003) · Oncogene · doi:10.1038/sj.onc.1206145 · Cited by 317
Chinni, S. R., Li, Y., Upadhyay, S., Koppolu, P. K., & Sarkar, F. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204365 · Cited by 315
Morrison, R. F., & Farmer, S. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17088 · Cited by 314
Transcriptional Activation of the Human p21 Gene by Retinoic Acid Receptor
Liu, M., Iavarone, A., & Freedman, L. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31723 · Cited by 301
Self-citationThe Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Kreis, N.-N., Louwen, F., & Yuan, J. (2019) · Cancers · doi:10.3390/cancers11091220 · Cited by 298
Transcriptional activation of the human insulin receptor gene by 1,25‐dihydroxyvitamin D3
Maestro, B., Molero, S., Bajo, S., Dávila, N., & Calle, C. (2002) · Cell Biochemistry and Function · doi:10.1002/cbf.951 · Cited by 288
p21WAF1 and tumourigenesis: 20 years after
Warfel, N. A., & El-Deiry, W. S. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835b639e · Cited by 286
Role of Vitamin D Beyond the Skeletal Function: A Review of the Molecular and Clinical Studies
Umar, M., Sastry, K. S., & Chouchane, A. I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061618 · Cited by 283
An update on vitamin D signaling and cancer
Carlberg, C., & Muñoz, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.018 · Cited by 281
AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression
Zeng, Y.-X., Somasundaram, K., & El-Deiry, W. S. (1997) · Nature Genetics · doi:10.1038/ng0197-78 · Cited by 280
Blain, S. W., Montalvo, E., & Massagué, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25863 · Cited by 279
Multiple functions of p27Kip1 and its alterations in tumor cells: a review
Sgambato, A., Cittadini, A., Faraglia, B., & Weinstein, I. B. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<18::aid-jcp3>3.0.co;2-s · Cited by 276
Afzal, S., Brondum-Jacobsen, P., Bojesen, S. E., & Nordestgaard, B. G. (2014) · BMJ · doi:10.1136/bmj.g6330 · Cited by 270
The pleiotropic actions of vitamin D
Lin, R., & White, J. H. (2004) · BioEssays · doi:10.1002/bies.10368 · Cited by 267
Staeva-Vieira, T. P., & Freedman, L. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1181 · Cited by 263
Self-citationRogatsky, I., Trowbridge, J. M., & Garabedian, M. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3181 · Cited by 257
Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer
Beer, T. M., Eilers, K. M., Garzotto, M., Egorin, M. J., Lowe, B. A., & Henner, W. D. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.117 · Cited by 253
Minucci, S., Nervi, C., Coco, F. L., & Pelicci, P. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204336 · Cited by 163
Kosugi, H., Towatari, M., Hatano, S., Kitamura, K., Kiyoi, H., Kinoshita, T., Tanimoto, M., Murate, T., Kawashima, K., Saito, H., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401508 · Cited by 150
Cross-talk between protein kinase C and multifunctional Ca2+/calmodulin-dependent protein kinase.
MacNicol, M., & Schulman, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49824-4 · Cited by 131
Metadata
- Authors
- Liu, M., Lee, M. H., Cohen, M., Bommakanti, M., & Freedman, L. P.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1996-01-15
- Volume
- 10
- Issue
- 2
- Pages
- 142-153
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2162741492
- Cited by
- 890
- References
- 58
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.